TPG Growth, a private equity investing entity, has agreed to sell Cancer Treatment Services International (CTSI) to New York-listed Varian Medical Systems for $283 million, three years after buying the oncology chain.
CTSI owns a network of cancer treatment facilities, under the American Oncology Institute brand, across India and South Asia, and AmPath, an integrated reference laboratory and pathology services provider in India.
CTSI is a part of Asia Healthcare Holdings (AHH), a platform founded by TPG Growth in 2017. The transaction is expected to close in two weeks, subject to the customary conditions. CTSI employs around 1,500 people in India and